TMEFF1 overexpression and its mechanism for tumor promotion in ovarian cancer

References

• SiegelRLMillerKDJemalACancer statistics, 2017CA Cancer J Clin201767173028055103
   PubMed Web of Science ®Google Scholar
• FrattaECoralSCovreAThe biology of cancer testis antigens: putative function, regulation and therapeutic potentialMol Oncol20115216418221376678
   PubMed Web of Science ®Google Scholar
• SalmaninejadAZamaniMRPourvahediMGolchehreZHosseini BereshnehARezaeiNCancer/testis antigens: expression, regulation, tumor invasion, and use in immunotherapy of cancersImmunol Invest201645761964027603913
   PubMed Web of Science ®Google Scholar
• CondominesMHoseDRèmeTGene expression profiling and real-time PCR analyses identify novel potential cancer-testis antigens in multiple myelomaJ Immunol2009183283284019542363
   PubMed Web of Science ®Google Scholar
• EibDWMartensGJA novel transmembrane protein with epidermal growth factor and follistatin domains expressed in the hypothalamohypophysial axis of Xenopus laevisJ Neurochem1996673104710558752111
   PubMed Web of Science ®Google Scholar
• GerySYinDXieDBlackKLKoefflerHPTMEFF1 and brain tumorsOncogene200322182723272712743596
   PubMed Web of Science ®Google Scholar
• RønnebergJAFleischerTSolvangHKMethylation profiling with a panel of cancer related genes: association with estrogen receptor, TP53 mutation status and expression subtypes in sporadic breast cancerMol Oncol201151617621212030
   PubMed Web of Science ®Google Scholar
• RasmussenSLKrarupHBSunesenKGPedersenISMadsenPHThorlacius-UssingOHypermethylated DNA as a biomarker for colorectal cancer: a systematic reviewColorectal Dis201618654956126998585
   PubMed Web of Science ®Google Scholar
• ZhuLHuZLiuJGaoJLinBGene expression profile analysis identifies metastasis and chemoresistance-associated genes in epithelial ovarian carcinoma cellsMed Oncol201532142625502083
   PubMed Web of Science ®Google Scholar
• NoelkerCSchwakeMBalzer-GeldsetzerMDifferentially expressed gene profile in the 6-hydroxy-dopamine-induced cell culture model of Parkinson’s diseaseNeurosci Lett20125071101522155091
   PubMed Web of Science ®Google Scholar
• SiegelDAHuangMKBeckerSFEctopic dendrite initiation: CNS pathogenesis as a model of CNS developmentInt J Dev Neurosci2002203–537338912175877
   PubMed Web of Science ®Google Scholar
• KanemotoNHorieMOmoriKNishinoNKondoMNoguchiKTanigamiAExpression of TMEFF1 mRNA in the mouse central nervous system: precise examination and comparative studies of TMEFF1 and TMEFF2Brain Res Mol Brain Res2001861–2485511165370
   PubMedGoogle Scholar
• ChangCEggenBJWeinsteinDCBrivanlouAHRegulation of nodal and BMP signaling by tomoregulin-1 (X7365) through novel mechanismsDev Biol2003255111112618130
   PubMed Web of Science ®Google Scholar
• Morais da SilvaSGatesPBEibDWMartensGJBrockesJPThe expression pattern of tomoregulin-1 in urodele limb regeneration and mouse limb developmentMech Dev20011041–212512811404089
   PubMed Web of Science ®Google Scholar
• ZhaoWTanPZhuQTgfbr2 inactivation facilitates cellular plasticity and development of Pten-null prostate cancerJ Mol Cell Biol201810431633029228234
   PubMed Web of Science ®Google Scholar
• HarmsPWChangCTomoregulin-1 (TMEFF1) inhibits nodal signaling through direct binding to the nodal coreceptor CriptoGenes Dev200317212624262914563676
   PubMed Web of Science ®Google Scholar
• EibDWHollingTMZwijsenAExpression of the follistatin/EGF-containing transmembrane protein M7365 (tomoregulin-1) during mouse developmentMech Dev2000971–216717111025219
   PubMed Web of Science ®Google Scholar
• UchidaTWadaKAkamatsuTA novel epidermal growth factor-like molecule containing two follistatin modules stimulates tyrosine phosphorylation of erbB-4 in MKN28 gastric cancer cellsBiochem Biophys Res Commun1999266259360210600548
   PubMed Web of Science ®Google Scholar
• WeePWangZEpidermal growth factor receptor cell proliferation signaling pathwaysCancers201795E5228513565
   PubMed Web of Science ®Google Scholar
• LiuQYuSZhaoWQinSChuQWuKEGFR-TKIs resistance via EGFR-independent signaling pathwaysMol Cancer20181715329455669
   PubMedGoogle Scholar
• GardiNLDeshpandeTUKambleSCBudheSRBapatSADiscrete molecular classes of ovarian cancer suggestive of unique mechanisms of transformation and metastasesClin Cancer Res2014201879924132919
   PubMed Web of Science ®Google Scholar
• KlymenkoYKimOStackMSComplex determinants of epithelial: mesenchymal phenotypic plasticity in ovarian cancerCancers (Basel)201798E104: 10428792442
   PubMed Web of Science ®Google Scholar
• VergaraDMerlotBLucotJPCollinetPVinatierDFournierISalzetMEpithelial-mesenchymal transition in ovarian cancerCancer Lett20102911596619880243
   PubMed Web of Science ®Google Scholar
• PagetSThe distribution of secondary growths in cancer of the breast. 1889Cancer Metastasis Rev198982981012673568
   PubMed Web of Science ®Google Scholar
• Moreno-BuenoGCubilloESarrióDGenetic profiling of epithelial cells expressing E-cadherin repressors reveals a distinct role for Snail, Slug, and E47 factors in epithelial-mesenchymal transitionCancer Res200666199543955617018611
   PubMed Web of Science ®Google Scholar
• PastushenkoIBrisebarreASifrimAIdentification of the tumour transition states occurring during EMTNature2018556770246346829670281
   PubMed Web of Science ®Google Scholar
• MullerPAVousdenKHp53 mutations in cancerNat Cell Biol20131512823263379
   PubMed Web of Science ®Google Scholar
• ColeAJDwightTGillAJAssessing mutant p53 in primary high-grade serous ovarian cancer using immunohistochemistry and massively parallel sequencingSci Rep201662619127189670
   PubMed Web of Science ®Google Scholar
• KihanaTTsudaHTeshimaSOkadaSMatsuuraSHirohashiSHigh incidence of p53 gene mutation in human ovarian cancer and its association with nuclear accumulation of p53 protein and tumor DNA aneuploidyJpn J Cancer Res19928399789841429209
   PubMedGoogle Scholar
• KupryjańczykJThorADBeauchampRMerrittVEdgertonSMBellDAYandellDWp53 gene mutations and protein accumulation in human ovarian cancerProc Natl Acad Sci U S A19939011496149658506342
   PubMed Web of Science ®Google Scholar
• LanglandGTYannoneSMLanglandRARadiosensitivity profiles from a panel of ovarian cancer cell lines exhibiting genetic alterations in p53 and disparate DNA-dependent protein kinase activitiesOncol Rep20102341021102620204287
   PubMed Web of Science ®Google Scholar
• DuranGEWangYCMoisanFFranciscoEBSikicBIDecreased levels of baseline and drug-induced tubulin polymerisation are hallmarks of resistance to taxanes in ovarian cancer cells and are associated with epithelial-to-mesenchymal transitionBr J Cancer2017116101318132828399108
   PubMed Web of Science ®Google Scholar
• KastanMBBerkovichEp53: a two-faced cancer geneNat Cell Biol20079548949117473858
   PubMed Web of Science ®Google Scholar
• ChinKVUedaKPastanIGottesmanMMModulation of activity of the promoter of the human MDR1 gene by Ras and p53Science199225550434594621346476
   PubMed Web of Science ®Google Scholar
• ZalcensteinAStambolskyPWeiszLMutant p53 gain of function: repression of CD95(Fas/APO-1) gene expression by tumor-associated p53 mutantsOncogene200322365667567612944915
   PubMed Web of Science ®Google Scholar
• VaughanCASinghSWindleBp53 mutants induce transcription of NF-κB2 in H1299 cells through CBP and STAT binding on the NF-κB2 promoter and gain of function activityArch Biochem Biophys20125181798822198284
   PubMed Web of Science ®Google Scholar
• ZalcensteinAWeiszLStambolskyPBarJRotterVOrenMRepression of the MSP/MST-1 gene contributes to the antiapoptotic gain of function of mutant p53Oncogene200625335936916170349
   PubMed Web of Science ®Google Scholar
• RupertusKDahlemCMengerMDSchillingMKKollmarORapamycin inhibits hepatectomy-induced stimulation of metastatic tumor growth by reduction of angiogenesis, microvascular blood perfusion, and tumor cell proliferationAnn Surg Oncol20091692629263719551445
   PubMed Web of Science ®Google Scholar
• SoriaJCOheYVansteenkisteJFLAURA InvestigatorsOsimertinib in untreated EGFR-mutated advanced non-small-cell lung cancerN Engl J Med2018378211312529151359
   PubMed Web of Science ®Google Scholar
• MirOBlanchetBGoldwasserFDrug-induced effects on erlotinib metabolismN Engl J Med2011365437938021793762
   PubMed Web of Science ®Google Scholar